This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Sirius XM, Chordiant Software: Midday Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were moving on above-average volume during Monday's session.

Sirius XM (SIRI - Get Report) was up a fraction of a penny to 91 cents on a spike in volume after the satellite radio provider upsized a debt offering of 8.75% notes due in 2015 from $550 million to $800 million. Barrington Research said the increased offer enables repayment of $500 million of 9.625% senior notes due 2013 as well as $244.4 million of senior secured term loan due 2012, with more than $50 million left over for general corporate purposes. The firm added that the positive fundamentals continue to provide the underpinnings for their favorable investment view. Volume topped 108 million shares, compared to the 50-day average daily volume of 94,000, according to the Nasdaq.

Chordiant Software (CHRD) surged by $1.16, or 30.5%, to $4.97 after Pegasystems (PEGA - Get Report) said it will buy the company for $161.5 million, or $5 per share. Volume topped 7.83 million shares, compared to the 50-day average daily volume of 194,000.

Star Scientific (CIGX) jumped by 33 cents, or 20.9%, to $1.91 after the tobacco company said in a regulatory filing that CEO Jonnie Williams bought 2.37 million shares at $1.14 per share on March 9. Volume topped 6.97 million shares, compared to the 50-day average daily volume of 1.14 million.

IntelliPharmaCeutics (IPCI - Get Report) gave back 72 cents, or 17.4%, to $3.42, retracing some of the stock's 166% surge on Friday. IntelliPharmaCeutics announced on Friday the settlement of a patent suit with Novartis Pharmaceuticals (NVS - Get Report) and Celgene (CELG - Get Report), although terms of the settlement were not disclosed. Volume topped 920,000 shares, compared to the 50-day average daily volume of 70,000.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CIGX $0.00 0.00%
CELG $121.53 0.00%
IPCI $2.55 0.00%
NVS $102.40 0.00%
PEGA $19.79 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs